Amarin Corp Plc (AMRN) News Headlines

▮ More

Date

Headline

1/7/2020 6:03:18 AM Amarin Reiterates 2020 Net Total Revenue Guidance At $650 Mln-$700 Mln

1/2/2020 6:05:08 AM Amarin Says VASCEPA Approved In Canada To Reduce Risk Of Cardiovascular Events

12/14/2019 3:14:45 AM Are These Biotech Companies Buyout Candidates? Deal Or No Deal?

12/13/2019 6:19:06 PM Amarin's Vascepa Gets FDA Approval For Expanded Use, Shares Up 5%

12/1/2019 11:26:57 PM Biotech Stocks Facing FDA Decision In December 2019

11/12/2019 8:59:48 PM Today's Top 5 Gainers In Healthcare Sector (AMRN, DMAC, TNXP...)

10/28/2019 12:24:06 AM Biotech Stocks Facing FDA Decision In November 2019

8/8/2019 6:17:14 PM FDA To Hold Advisory Committee Hearing For Amarin's Vascepa SNDA, Stock Fall 22%

8/8/2019 6:01:00 PM Amarin Does Not Expect FDA To Take Action On Vascepa SNDA By Prior Announced Sept. 28, 2019 PDUFA Goal Date

8/1/2019 4:04:07 AM AMRN'S Vascepa Hits Record Sales, ADMP Slumps On Stock Offering, SRDX On Watch…

7/17/2019 5:35:47 PM Amarin Says FDA Not Informed Whether It Plans To Hold An AdCom Meeting To Discuss SNDA For Vascepa

7/2/2019 10:12:18 PM 6 Top Gainers In Healthcare Sector (AMRN, DOVA, IMUX...)

7/2/2019 6:07:07 AM Amarin Boosts 2019 Guidance For Revenue To Range Of $380 Mln-$420 Mln

5/29/2019 6:19:58 AM Amarin: FDA Grants Priority Review For Vascepa SNDA Seeking Cardiovascular Risk Reduction Indication

2/27/2019 5:06:15 AM Amarin Q4 GAAP Loss Per Share $0.11; Non-GAAP Loss Per Share $0.09

1/10/2019 8:15:01 PM 6 Top Gainers In Healthcare Sector (PLXP, AMRN, MRTX...)

11/26/2018 9:00:24 PM Amarin Announces Pricing Of Underwritten Public Offering Of ADSs For Gross Proceeds Of About $200.0 Mln

11/11/2018 11:48:45 PM Vascepa Vs Placebo: AMRN Stands Behind REDUCE-IT Results

11/1/2018 5:11:11 AM Amarin Corp Q3 GAAP Net Loss $24.5 Mln Or $0.08/Shr Vs Loss $10.8 Mln Or $0.04/shr Last Year

10/11/2018 8:38:24 PM ATXI Abuzz, CRMD On Watch, AMRN Back In Focus